Clinical trialNCT01542034CompletedPhase 3Interventional

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

SponsorKythera BiopharmaceuticalsEnrollment506Moderate or Severe Submental Fullness

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Frederick Beddingfield, MD, PhD
Kythera Biopharmaceuticals, Inc
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

Investigational Site
Peterborough, Ontario, Canada
Investigational Site
Toronto, Ontario, Canada
Investigational Site
Toronto, Ontario, Canada
Investigational Site
Montreal, Quebec, Canada
Investigational Site
Vancouver, B.C., Canada

United States

Investigational Site
Birmingham, Alabama, United States
Investigational Site
Beverly Hills, California, United States
Investigational Site
Beverly Hills, California, United States
Investigational Site
Irvine, California, United States
Investigational Site
Los Angeles, California, United States
Investigational Site
Oceanside, California, United States
Investigational Site
San Diego, California, United States
Investigational Site
San Diego, California, United States
Investigational Site
New Haven, Connecticut, United States
Investigational Site
Washington D.C., District of Columbia, United States
Investigational Site
Miami Beach, Florida, United States
Investigational Site
West Palm Beach, Florida, United States
Investigational Site
Atlanta, Georgia, United States
Investigational Site
Snellville, Georgia, United States
Investigational Site
Arlington, Illinois, United States
Investigational Site
Chicago, Illinois, United States
Investigational Site
Evansville, Indiana, United States
Investigational Site
Louisville, Kentucky, United States
Investigational Site
Glenn Dale, Maryland, United States
Investigational Site
Hunt Valley, Maryland, United States
Investigational Site
Rockville, Maryland, United States
Investigational Site
West Bloomfield, Michigan, United States
Investigational Site
Fridley, Minnesota, United States
Investigational Site
Omaha, Nebraska, United States
Investigational Site
New York, New York, United States
Investigational Site
New York, New York, United States
Investigational Site
Charlotte, North Carolina, United States
Investigational Site
Nashville, Tennessee, United States
Investigational Site
Nashville, Tennessee, United States
Investigational Site
Charlottesville, Virginia, United States
Investigational Site
Spokane, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 29 Feb 2012
Primary completion: 31 May 2013
Completion: 31 Aug 2013
Last update posted: 15 Jun 2015
Registered enrollment: 506
Registry id: NCT01542034

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.